In addition to their antioxidant properties, whole grains may also reduce the risk of CHD through antithrombotic and decreased platelet-aggregating effects. Coagulation and fibrinolysis control the formation and resolution of fibrin and may affect risk of atherogenesis and thrombogenesis. Many have suggested that diet may serve an important role in the primary and secondary prevention of CHD through modifications in coagulation and fibrinolysis. In particular, diets low in fat and high in fiber result in a permanent increase in plasma fibrinolytic activity and a biphasic decrease in factor VIIc (13) . These changes favorably affect cardiovascular disease risk.
Although the estrogen-like properties of whole-grain phytoestrogens have been discussed, the vascular effects have not been characterized. Whole grains are a source of lignans, particularly, enterodiol, enterolactone, and matairesinol, which are diphenolic compounds having a structure similar to that of estrogenic compounds and that have been shown to be weakly estrogenic (12) . The phytoestrogens from whole grains share properties with soy isoflavones, which promote favorable vascular responses to stress. In a preliminary trial, 22 young adult rhesus monkeys with preexisting diet-induced atherosclerosis were subjected to 6 mo of dietary intervention. Dietary soy isoflavones were found to enhance the response to acetylcholine of atherosclerotic arteries in female monkeys. In addition, subsequent research by the same group also found that soy isoflavones promote endothelium-modulated dilation and inhibit constrictor responses to collagen infusion by inhibiting platelet aggregation or platelet release of vasoconstrictors (14) . In this manner, the phytochemical component of whole grains may be affecting CHD risk through changes in vascular health.
The effects of whole-grain foods on insulin resistance are of great potential importance in reducing the risk of CHD. The insulin resistance syndrome afflicts as many as 80 million US residents and is an important forerunner of type 2 diabetes (15). Dietary glycemic index has been shown to be positively associated with risk of both diabetes (5) and CHD (4). Whole-grain intake addresses several CHD risk factors associated with the insulin Liu et al (4) have presented convincing data that support the hypothesis that increasing the consumption of whole-grain foods may protect against CHD. However, as the authors concede, a major limitation of observational studies is that even strong associations do not ensure causal relations. Prospective, controlled clinical trials are required to assess strong links between dietary components and disease states, but they are difficult to perform because it is almost impossible to provide control foods that are similar enough to the study foods to ensure blinding of investigators and volunteers. Long-term clinical trials with specific foods have not been done; therefore, this evidence is not available.
Thus, studies strongly suggest that the regular consumption of whole grains significantly reduces the risk of CHD (2-4). The estimated risk reduction with the highest measured intake of whole-grain intake is Ϸ28% (risk ratios of 0.70-0.74). Therefore, it may be prudent for health-care professionals to recommend to those individuals who may be at increased risk of CHD to follow the US Department of Agriculture Food Guide Pyramid recommendation to consume 6-11 servings of grains/d (8) . From the work of Liu et al and previous publications, it appears that consumption of 2-3 servings of whole grains/d may have significant benefits in the prevention of cardiovascular disease. Recommending that an individual incorporate moderate amounts of whole grains, including dark bread, whole-grain breakfast cereals, popcorn, cooked oatmeal, or brown rice in their diet may have important implications in the prevention of Western diseases.
